These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 825252)

  • 1. [Immunization by Canadida albicans and non-specific immunostimulation by Corynebacterium granulosum and BCG in experimental candidiasis].
    Drouhet E; Dupont B
    C R Acad Hebd Seances Acad Sci D; 1976 Nov; 283(11 D):1385-8. PubMed ID: 825252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
    Sher NA; Chaparas SD; Greenberg LE; Bernard S
    Infect Immun; 1975 Dec; 12(6):1325-30. PubMed ID: 1107224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic activity of the cell walls of mycobacteria, nocardia, corynebacteria and anaerobic coryneforms.
    Azuma I; Taniyama T; Sugimura K; Aladin A; Yamamura Y
    Jpn J Microbiol; 1976 Aug; 20(4):263-71. PubMed ID: 824484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Corynebacterium pseudotuberculosis and the effect of adjuvants in mice.
    Brogden KA; Cutlip RC; Lehmkuhl HD
    J Comp Pathol; 1985 Apr; 95(2):167-73. PubMed ID: 3837788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 6. Phagocytic and antimicrobial activities of rabbit peritoneal and alveolar macrophages activated with Mycobacterium bovis BCG on Candida albicans.
    Gontijo PP; Wayne LG
    Rev Latinoam Microbiol; 1978; 20(1):41-4. PubMed ID: 375350
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice.
    Hurtrel B; Langrange PH; Michel JC
    Infect Immun; 1981 Jan; 31(1):95-101. PubMed ID: 7012009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant protection against bacterial infection in granulocytopenic mice.
    Buhles WC; Shifrine M
    J Infect Dis; 1977 Jul; 136(1):90-5. PubMed ID: 328788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization of mice by combinations of inactive fractions of Mycobacterium bovis strain BCG.
    Anacker RL; Bickel WD; Brehmer W; Niwa M; Ribi E; Tarmina DF
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):723-30. PubMed ID: 4975293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antigenic preparations for the immunodiagnosis of candidiasis].
    Karaev ZO; Babenko GA; Ignat'eva SM; Solov'eva GI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):104-10. PubMed ID: 2251882
    [No Abstract]   [Full Text] [Related]  

  • 14. The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cells.
    Olsson L; Ebbesen P; Kiger N; Florentin I; Mathé G
    Eur J Cancer (1965); 1978 Apr; 14(4):355-62. PubMed ID: 348478
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection.
    Hurtrel B; Lagrange PH; Michel JC
    Ann Immunol (Paris); 1980; 131C(1):105-18. PubMed ID: 6249181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1973 May; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.